3rd Quarter - Report

HEALTH AND MEDICINE COUNSEL for NEPHURE

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act

LobbyistCovered position, as disclosed
SARAH BUCHANAN Legislative Consultant
DALE P DIRKS Legislative Consultant

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Bills named: H.R. 1325 (113th), S. 323 (113th)

Budget/Appropriations BUD

FY15 L-HHS FY15 MilCon-VA FY15 Defense

LobbyistCovered position, as disclosed
SARAH BUCHANAN Legislative Consultant
DALE P DIRKS Legislative Consultant

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.